Beurs gesloten -
Nasdaq
22:30:00 03-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1,7
USD
|
-1,73%
|
|
-58,64%
|
-18,84%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
-
|
545,9
|
146,9
|
16,52
|
3,655
|
Bedrijfswaarde
1 |
-
|
500,7
|
134,8
|
7,923
|
-1,089
|
K/w-verhouding
|
-148
x
|
-2,05
x
|
-1,74
x
|
-0,18
x
|
-0,18
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
45.054.868
x
|
9.556.978
x
|
927.856
x
|
209.865
x
|
Bedrijfswaarde/omzet
|
-
|
41.319.290
x
|
8.767.919
x
|
445.103
x
|
-62.512
x
|
Bedrijfswaarde/EBITDA
|
-
|
-21,5
x
|
-3,83
x
|
-0,31
x
|
0,08
x
|
Bedrijfswaarde/FCF
|
-
|
-26.129.251
x
|
-3.171.857
x
|
-1.342.456
x
|
484.764
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
128
x
|
1,94
x
|
1,13
x
|
0,33
x
|
0,15
x
|
Aantal aandelen (in duizenden)
|
-
|
2.045
|
1.580
|
1.793
|
1.745
|
Referentieprijs
2 |
303,3
|
267,0
|
93,00
|
9,210
|
2,094
|
Datum van publicatie
|
6/08/20
|
30/03/21
|
24/03/22
|
30/03/23
|
1/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
|
-
|
7,834
|
12,12
|
15,37
|
17,8
|
17,42
|
EBITDA
1 |
-5,309
|
-35,06
|
-23,26
|
-35,19
|
-25,49
|
-13,22
|
Bedrijfsresultaat (EBIT)
1 |
-5,408
|
-36,54
|
-26,85
|
-38,7
|
-29,16
|
-15,59
|
Operationele Marge
|
-
|
-466,43%
|
-221,56%
|
-251,72%
|
-163,82%
|
-89,53%
|
Resultaat voor belastingen (EBT)
1 |
6,405
|
-45,98
|
-36,68
|
-44,78
|
-72,52
|
-19,73
|
Nettowinst (verlies)
1 |
7,361
|
-39,53
|
-36,68
|
-45,73
|
-66,16
|
-17,9
|
Nettomarge
|
-
|
-504,6%
|
-302,67%
|
-297,42%
|
-371,71%
|
-102,77%
|
WPA
|
-
|
-2,052
|
-130,1
|
-53,40
|
-51,70
|
-11,42
|
Free Cash Flow
|
-
|
-45,46
|
-19,16
|
-42,5
|
-5,902
|
-2,246
|
FCF-marge
|
-
|
-580,32%
|
-158,13%
|
-276,43%
|
-33,16%
|
-12,9%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
6/08/20
|
6/08/20
|
30/03/21
|
24/03/22
|
30/03/23
|
1/04/24
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
---|
Omzet
1 |
4,031
|
4,194
|
5,224
|
4,657
|
3,305
|
4,614
|
3,978
|
4,981
|
3,82
|
EBITDA
1 |
-5,985
|
-7,791
|
-6,699
|
-6,273
|
-5,364
|
-
|
-3,894
|
-2,122
|
-2,634
|
Bedrijfsresultaat (EBIT)
1 |
-9,684
|
-11,64
|
-11,89
|
-8,198
|
-7,191
|
-28,82
|
-4,13
|
-3,175
|
-3,377
|
Operationele Marge
|
-240,24%
|
-277,63%
|
-227,66%
|
-176,04%
|
-217,58%
|
-624,62%
|
-103,82%
|
-63,74%
|
-88,4%
|
Resultaat voor belastingen (EBT)
1 |
1,009
|
-22,99
|
-16,08
|
-1,046
|
-26,81
|
-28,52
|
-4,151
|
-3,261
|
-7,271
|
Nettowinst (verlies)
1 |
0,995
|
-24
|
-16,14
|
-1,046
|
-20,16
|
-28,82
|
-4,081
|
-3,595
|
-5,138
|
Nettomarge
|
24,68%
|
-572,25%
|
-308,96%
|
-22,46%
|
-610,08%
|
-624,53%
|
-102,59%
|
-72,17%
|
-134,5%
|
WPA
2 |
1,200
|
-27,90
|
-17,40
|
-0,9000
|
-14,40
|
-21,00
|
-2,700
|
-2,400
|
-3,250
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10/11/21
|
24/03/22
|
12/05/22
|
11/08/22
|
9/11/22
|
30/03/23
|
11/05/23
|
14/08/23
|
9/11/23
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
21,7
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
7,05
|
-
|
45,3
|
12,1
|
8,59
|
4,74
|
Hefboom (schuld/ebitda)
|
-
|
-0,6185
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-45,5
|
-19,2
|
-42,5
|
-5,9
|
-2,25
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-99,1%
|
-44,6%
|
-54,4%
|
-117%
|
-61,3%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-27,8%
|
-12,8%
|
-17,2%
|
-21,7%
|
-23,4%
|
Totale activa
1 |
-
|
142,3
|
285,9
|
266,6
|
305,4
|
76,53
|
Nettoactief per aandeel
|
-
|
2,360
|
138,0
|
82,10
|
27,80
|
14,00
|
Cashflow per aandeel
|
-
|
0,6300
|
95,40
|
42,00
|
8,560
|
3,950
|
Capex
1 |
4,47
|
18,7
|
3,67
|
7,28
|
1,31
|
0,03
|
Capex/omzet
|
-
|
238,38%
|
30,25%
|
47,35%
|
7,34%
|
0,18%
|
Datum van publicatie
|
6/08/20
|
6/08/20
|
30/03/21
|
24/03/22
|
30/03/23
|
1/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -18,84% | 2,98 mln. | | +39,33% | 6,11 mld. | | -18,38% | 4,35 mld. | | -9,17% | 3,19 mld. | | +3,98% | 3,15 mld. | | -3,41% | 2,51 mld. | | +48,74% | 1,98 mld. | | -4,82% | 1,74 mld. | | -1,24% | 1,63 mld. | | -8,96% | 1,6 mld. |
Alternatieve geneeskunde
|